This section shows a general overview of information for the selected study (COSU identifier) or publication (COSP identifier). Studies may have been performed by the Sanger Institute Cancer Genome Project, or imported from the ICGC/TCGA. You can see more information on the help pages.
- ICGC(GACA-CN) : Gastric Cancer - CN
- Study ID
- ICGC Project Summary:
In view of its high prevalence in China and the existence of possible interacting environmental factors, China will focus on gastric cancer as a part of the International Cancer Genome Consortium activities. In particular, China will focus both on Intestinal-type and diffuse-type cancer. The major reasons for selection of gastric cancer are:
- It is the most common cancer with high incidence and poor prognosis in China, most of cancer patients to be diagnostic too later to cure.
- Intestinal- type and diffuse-type cancer is different in clinical pathological features and gene expression profiling.
- About 50-80% of cancers have the high risk of recurrence and metastasis following creative resection.
- Precancerous lesion including intestinal metaplasia (IM) and dysplasia (Dys) has high incidence and have a high risk to be transformed to malignance.
- It is fundamental to analyze genomic changes for discovering biomarkers to detect gastric cancer early and to predict prognosis.
- Genes Analysed
- Mutated Samples
- Total No. of Samples